X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36) 36
humans (28) 28
surgery (21) 21
diagnosis (17) 17
male (16) 16
bandages, dressings or absorbent pads (15) 15
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (15) 15
filters implantable into blood vessels (15) 15
first-aid kits (15) 15
fomentation (15) 15
human necessities (15) 15
hygiene (15) 15
identification (15) 15
medical or veterinary science (15) 15
orthopaedic, nursing or contraceptive devices (15) 15
prostheses (15) 15
treatment or protection of eyes or ears (15) 15
adult (14) 14
female (14) 14
animals (13) 13
oncology (13) 13
middle aged (12) 12
hematology (11) 11
mice (11) 11
aged (10) 10
annan fysik (7) 7
cancer (7) 7
experimental physics (7) 7
experimentell fysik (7) 7
fysik (7) 7
nanowires (7) 7
natural sciences (7) 7
naturvetenskap (7) 7
other physics topics (7) 7
physical sciences (7) 7
treatment outcome (7) 7
expression (6) 6
gene expression regulation, neoplastic (6) 6
lymphomas (6) 6
prognosis (6) 6
abridged index medicus (5) 5
aged, 80 and over (5) 5
cell line, tumor (5) 5
chemotherapy (5) 5
growth (5) 5
in2o3 (5) 5
lymphoma, large-cell, anaplastic - genetics (5) 5
mice, inbred nod (5) 5
mice, scid (5) 5
mutation (5) 5
receptor protein-tyrosine kinases - genetics (5) 5
sensors (5) 5
signal transduction (5) 5
adolescent (4) 4
cells (4) 4
gas sensors (4) 4
gene (4) 4
gene expression profiling (4) 4
genetic aspects (4) 4
kinase (4) 4
metal oxides (4) 4
nanobelts (4) 4
nanostructure (4) 4
nanotechnology (4) 4
receptor protein-tyrosine kinases - metabolism (4) 4
transplantation (4) 4
young adult (4) 4
analysis (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biomarkers, tumor - genetics (3) 3
cell proliferation (3) 3
child (3) 3
combined modality therapy (3) 3
cytarabine (3) 3
cytarabine - adverse effects (3) 3
disease-free survival (3) 3
follow-up studies (3) 3
hek293 cells (3) 3
hematology, oncology and palliative medicine (3) 3
hemic and lymphatic diseases (3) 3
immunology (3) 3
instruments & instrumentation (3) 3
kaplan-meier estimate (3) 3
methotrexate (3) 3
methotrexate - adverse effects (3) 3
methotrexate - therapeutic use (3) 3
molecular targeted therapy (3) 3
nanocomposites (3) 3
nanomaterials (3) 3
non-hodgkins-lymphoma (3) 3
original research (3) 3
peripheral t-cell (3) 3
pharmacokinetics (3) 3
phenotype (3) 3
physics, applied (3) 3
rats (3) 3
response criteria (3) 3
reverse transcriptase polymerase chain reaction (3) 3
rna, messenger - genetics (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Cell, ISSN 1535-6108, 04/2015, Volume 27, Issue 4, pp. 516 - 532
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2015, Volume 125, Issue 12, pp. 1922 - 1931
Journal Article
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
Journal Article
Sensors & Actuators: B. Chemical, ISSN 0925-4005, 2007, Volume 121, Issue 1, pp. 208 - 213
Quasi one-dimensional nanostructures of semiconducting metal oxides are promising for the development of nano-devices. Tin, indium, and zinc oxides were... 
Ozone | SnO 2 | ZnO | Nanowires | In 2O 3 | SnO | ELECTROCHEMISTRY | CHEMISTRY, ANALYTICAL | INSTRUMENTS & INSTRUMENTATION | nanowires | In2O3 | DNA | IN2O3 NANOWIRES | SnO2 | NANOBELTS | SENSORS | ozone | Nanotechnology | Metal oxides | Actuators | Nanocomposites | Nanomaterials | Nanostructure | Indium | Microstructure | Annan fysik | Experimental physics | InO | Fysik | Physical Sciences | Naturvetenskap | Other Physics Topics | Natural Sciences | Experimentell fysik
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 10/2017, Volume 58, Issue 10, pp. 1638 - 1645
The present translational study aimed to verify whether serial 18F-FDG PET/CT predicts doxorubicin cardiotoxicity. Methods: Fifteen athymic mice were treated... 
FDG PET/CT | Doxorubicin | Myocardial metabolism | Index Medicus
Journal Article